1,5-Pentanediol

1,5-Pentanediol

SCHEMBL2966670

CS(=O)(=O)O.CS(=O)(=O)O.OCCCCCO

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB2AGTR1BCL2BCL2A1BCL2L1BCL2L10BCL2L2BCRBRAFCHRM1CHRNA10CHRNA9DRD1DRD2DRD3DRD4DRD5EGFRF2FLT1FLT4GCKGHSRGNRHRGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHTR1AHTR1BHTR1DHTR2AHTR2CHTR3AIDH2KDRKITMAOBMCL1MTTPPP4HBPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PIKFYVEROCK1ROCK2SLC18A2SLC6A2SLC6A3SLC6A4TACR1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8gyrAgyrBparCparEpol

The experimentally established mechanism targets of 1,5-Pentanediol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.47
ALDH1A1 P00352 2/20 0.47
HSD17B10 Q99714 1/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
TSHR P16473 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.42
TDP1 Q9NUW8 1/20 0.41
GPR84 Q9NQS5 1/20 0.41
FFAR1 O14842 1/20 0.41
FFAR4 Q5NUL3 1/20 0.41
CA2 P00918 5/20 0.39
CA1 P00915 3/20 0.39
CA12 O43570 1/20 0.39
CA9 Q16790 1/20 0.39
KDM4E B2RXH2 1/20 0.39
GRIA1 P42261 3/20 0.36
FNTA P49354 1/20 0.36
FNTB P49356 1/20 0.36
ATR Q13535 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4298844 1.00 LMNA (0.47) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL28384587 1.00 LMNA (0.47) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL4300373 1.00 LMNA (0.47) LMNAALDH1A1HSD17B10MEN1KMT2A
1,6-Hexanediol SCHEMBL2180296 1.00 LMNA (0.47) LMNAALDH1A1HSD17B10MEN1KMT2A
1,4-Butanediol SCHEMBL130918 0.97 SMN1; SMN2 (0.44) LMNAALDH1A1HSD17B10MEN1KMT2A
1,4-Butanediol SCHEMBL15301979 0.97 SMN1; SMN2 (0.44) LMNAALDH1A1HSD17B10MEN1KMT2A
1,3-Propanediol SCHEMBL7758303 0.90 ALDH1A1 (0.39) LMNAALDH1A1HSD17B10MEN1KMT2A
1,3-Propanediol SCHEMBL576409 0.90 ALDH1A1 (0.39) LMNAALDH1A1HSD17B10MEN1KMT2A
1,5-Pentanediol SCHEMBL2168837 0.89 GPR84 (0.46) LMNAALDH1A1HSD17B10MEN1KMT2A
Decanol SCHEMBL9046992 0.89 LMNA (0.68) LMNAALDH1A1HSD17B10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12500268-B2 Nonaqueous electrolyte additive, nonaqueous electrolyte containing same, power storage device, and electric device AESC JAPAN LTD. (JP) 2025-12-16 US disclosed
EP-4273989-A1 SULFATE COMPOUND, NONAQUEOUS ELECTROLYTE CONTAINING SAME, AND POWER STORAGE DEVICE AESC Japan Ltd. (JP) 2023-11-08 EP disclosed
CN-116648804-A Sulfate compound, nonaqueous electrolyte containing same, and electricity storage device 远景动力技术(江苏)有限公司 2023-08-25 CN disclosed
US-20230253622-A1 NONAQUEOUS ELECTROLYTE ADDITIVE, NONAQUEOUS ELECTROLYTE CONTAINING SAME, POWER STORAGE DEVICE, AND ELECTRIC DEVICE ENVISION DYNAMICS TECHNOLOGY (JIANGSU) CO., LTD. (CN) 2023-08-10 US disclosed
CN-115668568-A Sulfate compound, nonaqueous electrolyte solution containing same, and electricity storage device 远景动力技术(江苏)有限公司 2023-01-31 CN disclosed
WO-2022141010-A1 SULFATE COMPOUND, NONAQUEOUS ELECTROLYTE CONTAINING SAME, AND POWER STORAGE DEVICE 远景动力技术(江苏)有限公司 2022-07-07 WO disclosed
WO-2022082759-A1 SULPHATE COMPOUND AND NON-AQUEOUS ELECTROLYTE AND POWER STORAGE DEVICE CONTAINING SAME 远景动力技术(江苏)有限公司 2022-04-28 WO disclosed
US-10660969-B2 Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2020-05-26 US disclosed
US-10434182-B2 Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2019-10-08 US disclosed
US-20180214561-A1 EIGHT-ARM POLYETHYLENE GLYCOL DERIVATIVE, PRODUCTION METHOD THEREFOR, AND MODIFIEDBIO-RELATEDSUBSTANCETHEREOF XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2018-08-02 US disclosed
US-20120301797-A1 NON-AQUEOUS ELECTROLYTIC SOLUTION, ELECTROCHEMICAL ELEMENT USING SAME, AND ALKYNYL COMPOUND USED THEREFOR UBE INDUSTRIES, LTD. (JP) 2012-11-29 US disclosed
US-20120282529-A1 NONAQUEOUS ELECTROLYTE AND ELECTROCHEMICAL ELEMENT USING THE SAME UBE INDUSTRIES, LTD. (JP) 2012-11-08 US disclosed
EP-2479831-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME Ube Industries, Ltd. (JP) 2012-07-25 EP disclosed
US-20100255384-A1 Nonaqueous electrolyte secondary battery PANASONIC ENERGY CO., LTD (JP) 2010-10-07 US disclosed
US-7767343-B2 Nonaqueous electrolyte secondary battery using lithium cobalt oxide as a positive active material and a nonaqueous electrolyte containing a sulfonyl-containing compound UBE INDUSTRIES LTD. (JP) 2010-08-03 US disclosed
US-7629085-B2 sulfur-containing acid ester and an alkyne-containing compound; excellent battery characteristics in cycle performance, electric capacity and storage property; e.g. 2-propynyl methyl carbonate and 1,3-propanesultone UBE INDUSTRIES, LTD. (JP) 2009-12-08 US disclosed
US-20070231707-A1 Nonaqueous Electrolytic Solution and Lithium Secondary Battery MU IONIC SOLUTIONS CORPORATION (JP) 2007-10-04 US disclosed
EP-1772924-A1 NONAQUEOUS ELECTROLYTIC SOLUTION AND LITHIUM SECONDARY BATTERY Ube Industries, Ltd. (JP) 2007-04-11 EP disclosed
EP-1739783-A1 NONAQUEOUS ELECTROLYTE SECONDARY BATTERY Ube Industries, Ltd. (JP) 2007-01-03 EP disclosed
US-20060166096-A1 Nonaqueous electrolyte secondary battery PANASONIC ENERGY CO., LTD (JP) 2006-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10434182-B2 Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof MRPL38, ALG8, MRPS18A LMNA 4044/4885ALDH1A1 1103/4885HSD17B10 1150/4885
US-10660969-B2 Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof MRPL38, ALG8, COG8 LMNA 3900/4885ALDH1A1 787/4885HSD17B10 1023/4885
US-20180214561-A1 EIGHT-ARM POLYETHYLENE GLYCOL DERIVATIVE, PRODUCTION METHOD THEREFOR, AND MODIFIEDBIO-RELATEDSUBSTANCETHEREOF MRPL38, CXCL8, ALG8 LMNA 3842/4885ALDH1A1 1061/4885HSD17B10 759/4885
US-20120301797-A1 NON-AQUEOUS ELECTROLYTIC SOLUTION, ELECTROCHEMICAL ELEMENT USING SAME, AND ALKYNYL COMPOUND USED THEREFOR WEE2, WEE1, NOTUM LMNA 1993/4885ALDH1A1 1289/4885HSD17B10 1535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.